Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study

Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study

Highlights

• A randomized, placebo-controlled trial of adjunct homeopathy with standard of care for COVID-19 was conducted on 300 patients.
• Primary outcome on total symptom score measured over 10 days decreased significantly favoring Standard of care + Homeopathy.
• Recovery was earlier in Standard of care + Homeopathy group by 02 days showing the added benefits of homeopathy.
• Resolution of fever was 20 h earlier in Standard of care + Homeopathy.
• Arsenicum album, Bryonia alba and Phosphorus were the most frequently prescribed medicines.

https://www.researchgate.net/publication/360461274_Efficacy_of_individualized_homeopathy_as_an_adjunct_to_standard_of_care_of_COVID-19_A_randomized_single-blind_placebo-controlled_study